Looks bad - and is a transparent attempt at damage limitation and to swing opinion that the administration is doing all it can.
But a recent Forbes article on the company's pricing decision for the drug suggests it is not as effective as has been touted. So have they just bought up 90% of the world's snake oil production?
Looks bad - and is a transparent attempt at damage limitation and to swing opinion that the administration is doing all it can.
But a recent Forbes article on the company's pricing decision for the drug suggests it is not as effective as has been touted. So have they just bought up 90% of the world's snake oil production?
https://www.forbes.com/sites/williamhaseltine/2020/06/29/the-other-shoe-drops-gileads-outrageous-pricing-of-remdesivir/#360ebd0e8d1f
I don't know enough about the treatment to have formed an opinion either way - this was not my area when I worked in pharma.